Validity and Reliability of the 6 Minute Pegboard Ring Test

January 11, 2024 updated by: Çağtay Maden

Validity and Reliability of the 6 Minute Pegboard Ring Test in Duchenne Muscular Dystrophy Patients

This study aimed to investigate the validity and reliability of 6PBRT in individuals with DMD and its applicability on these patients.

Study Overview

Status

Completed

Detailed Description

Duchenne muscular dystrophy (DMD) is the most common type of progressive muscular dystrophies and is an X-linked recessive, rarely autosomal dominant, muscle disease. DMD begins in childhood and progresses until they become unable to walk. Individuals with DMD experience skeletal muscle weakness, difficulty breathing, and decreased exercise capacity. In these patients, traditionally lower extremity tests are; 6-minute walk tests, treadmill tests and Cardiopulmonary exercise tests are used. However, it is reported that the upper extremity is also affected in individuals with DMD. The 6-Minute Pegboard and Ring Test (6PBRT), which is valid and reliable in most disease groups, is also a test that can be applied to the upper extremities. It is important to use 6PBRT frequently in clinical research practice for patients with DMD and to know its validity and reliability. To our knowledge, the validity and reliability of this test in individuals with DMD has not been established in the literature. This study aimed to investigate the validity and reliability of 6PBRT in individuals with DMD and its applicability on these patients.

Study Type

Observational

Enrollment (Actual)

22

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Şahinbey
      • Gaziantep, Şahinbey, Turkey, 27000
        • Gaziantep Islamic Science and Technology University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Individuals diagnosed with Duchenne muscular dystrophy

Description

Inclusion Criteria:

  • Volunteering to participate in the research,
  • Being diagnosed with Duchenne muscular dystrophy between the ages of 6-17,
  • Being Level 1 and 2 according to the Brooke Upper Extremity Functional Classification Scale
  • Having no problems reading and/or understanding the scales and cooperating with the tests to be.
  • Ability to sit independently for approximately 15 minutes during the evaluation

Exclusion Criteria:

  • Not volunteering to participate in the research,
  • Having any orthopedic problem in the upper extremity,
  • A neurological disease or other clinical condition that may affect cognitive status having a diagnosis,
  • Having had surgery on the upper extremities in the last 6 months and any having an injury
  • At a level that prevents functional activities in the upper extremity Having severe contractures (joint restriction)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
6 Minute Pegboard and Ring Test
Time Frame: A total of two measurements will be made at 1-week intervals within 6 months.
The 6-minute pegboard and ring test is used to assess upper extremity functional capacity. The patient sat in front of a perforated board with bottom pegs at shoulder level. The upper pegs are placed in the hole 20 cm above the lower pegs. 10 rings of the same size are placed on the lower pegs. The patient is asked to move as many rings as possible from the lower pegs to the upper pegs and vice versa within a 6-minute period. Pulse, blood pressure, SpO₂, dyspnea and arm fatigue detection are recorded before/after each test. Before the actual test, patients are allowed to move up and down the rings in a cycle to become familiar with the testing procedure. If the patient wants to rest during the test, he is allowed, but the stopwatch is not stopped. During the test, standard encouraging phrases are said to the patient at the end of each minute.
A total of two measurements will be made at 1-week intervals within 6 months.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quick Shoulder-Hand Syndromes Questionnaire
Time Frame: A total of two measurements will be made at 1-week intervals within 6 months.
The Quick Shoulder-Hand Syndromes Questionnaire is used to evaluate musculoskeletal physical function and symptoms of the upper extremity. The survey consists of 11 items and is scored between 0-100 points. Higher scores indicate more disability
A total of two measurements will be made at 1-week intervals within 6 months.
Assessment of muscle strength
Time Frame: A total of two measurements will be made at 1-week intervals within 6 months.
Muscle strength will be measured using a digital dynamometer (Manual Muscle Tester™), shoulder flexor, shoulder abductor, elbow extensor and elbow flexor muscle strength. Muscle tests will be repeated three times for each side and the highest value will be recorded in kg. Muscle strength will be calculated as percentages of expected values.
A total of two measurements will be made at 1-week intervals within 6 months.
The Pediatric Quality of Life Inventory
Time Frame: A total of two measurements will be made at 1-week intervals within 6 months.
The health-related quality of life of the participants will be evaluated with the Turkish version PedsQL-3.0 Neuromuscular Module. The scale consists of 3 categories containing 25 items. These categories; It includes 17 items regarding the disease process and related symptoms, 3 items regarding communication skills, and 5 items regarding the family's financial and social support systems. The items of the scale are scored between 4 (always poses a problem) and 0 (never poses a problem). At the end of the scale, a score between 0 and 4 is made. A score close to 100 indicates that the health-related quality of life is at a better level.
A total of two measurements will be made at 1-week intervals within 6 months.
Brooke Upper Extremity Functional Classification Scale
Time Frame: A total of two measurements will be made at 1-week intervals within 6 months.

It will be used to evaluate the upper extremity functional level of the individuals who will be included in the study. It was developed to determine the functional level of the upper extremity in the clinical evaluation of DMD (11). The steps of this scale are as follows; Level 1: Begins to move with the arms at the sides and can fully clasp the hands above the head.

Level 2: However, he can bring his arms above his head by flexing his elbows or use his accessory muscles Level 3: He cannot raise his hands above his head, but he can bring the glass to his mouth (uses both hands if necessary).

Level 4: He can raise his hands to his mouth, but cannot lift a glass of water to his mouth.

Level 5: Cannot raise hands to mouth, but can raise hands to hold a pen or pick up a coin from the table.

Level 6: He cannot raise his hands up to his mouth and cannot use his hands functionally.

A total of two measurements will be made at 1-week intervals within 6 months.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Çağtay MADEN, PhD, Gaziantep Islamic Science and Technology University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 30, 2023

Primary Completion (Actual)

December 30, 2023

Study Completion (Actual)

January 1, 2024

Study Registration Dates

First Submitted

November 20, 2023

First Submitted That Met QC Criteria

December 7, 2023

First Posted (Actual)

December 18, 2023

Study Record Updates

Last Update Posted (Actual)

January 12, 2024

Last Update Submitted That Met QC Criteria

January 11, 2024

Last Verified

May 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Duchenne Muscular Dystrophy

Subscribe